TY - JOUR
T1 - Enabling real time release testing by NIR prediction of dissolution of tablets made by continuous direct compression (CDC)
AU - Pawar, Pallavi
AU - Wang, Yifan
AU - Keyvan, Golshid
AU - Callegari, Gerardo
AU - Cuitino, Alberto
AU - Muzzio, Fernando
N1 - Funding Information:
The authors wish to acknowledge the support of the Food and Drug Administration under the grant number DHHS-FDA U01 FD005535-01, and the National Science Foundation under Grant number IIP-1237873, for Developing & Implementing Non-Destructive Characterization and Assessment of Pharmaceutical Oral Dosages in Continuous Manufacturing.
Publisher Copyright:
© 2016
PY - 2016/10/15
Y1 - 2016/10/15
N2 - A method for predicting dissolution profiles of directly compressed tablets for a fixed sustained release formulation manufactured in a continuous direct compaction (CDC) system is presented. The methodology enables real-time release testing (RTRt). Tablets were made at a target drug concentration of 9% Acetaminophen, containing 90% lactose and 1% Magnesium Stearate, and at a target compression force of 24 kN. A model for predicting dissolution profiles was developed using a 34−1 fractional factorial experimental design built around this targeted condition. Four variables were included: API concentration (low, medium, high), blender speed (150 rpm, 200 rpm, 250 rpm), feed frame speed (20 rpm, 25 rpm, 30 rpm), compaction force (8KN, 16KN, 24KN). The tablets thus obtained were scanned at-line in transmission mode using Near IR spectroscopy. The dissolution profiles were described using two approaches, a model-independent “shape and level” method, and a model-dependent approach based on Weibull's model. Multivariate regression was built between the NIR scores as the predictor variables and the dissolution profile parameters as the response. The model successfully predicted the dissolution profiles of the individual tablets (similarity factor, f2 ∼72) manufactured at the targeted set point. This is a first ever published manuscript addressing RTRt for dissolution prediction in continuous manufacturing, a novel and state of art technique for tablet manufacturing.
AB - A method for predicting dissolution profiles of directly compressed tablets for a fixed sustained release formulation manufactured in a continuous direct compaction (CDC) system is presented. The methodology enables real-time release testing (RTRt). Tablets were made at a target drug concentration of 9% Acetaminophen, containing 90% lactose and 1% Magnesium Stearate, and at a target compression force of 24 kN. A model for predicting dissolution profiles was developed using a 34−1 fractional factorial experimental design built around this targeted condition. Four variables were included: API concentration (low, medium, high), blender speed (150 rpm, 200 rpm, 250 rpm), feed frame speed (20 rpm, 25 rpm, 30 rpm), compaction force (8KN, 16KN, 24KN). The tablets thus obtained were scanned at-line in transmission mode using Near IR spectroscopy. The dissolution profiles were described using two approaches, a model-independent “shape and level” method, and a model-dependent approach based on Weibull's model. Multivariate regression was built between the NIR scores as the predictor variables and the dissolution profile parameters as the response. The model successfully predicted the dissolution profiles of the individual tablets (similarity factor, f2 ∼72) manufactured at the targeted set point. This is a first ever published manuscript addressing RTRt for dissolution prediction in continuous manufacturing, a novel and state of art technique for tablet manufacturing.
KW - Continuous manufacturing
KW - Dissolution prediction
KW - Feeders
KW - Near IR spectroscopy
KW - Real time release
KW - Tablets
UR - http://www.scopus.com/inward/record.url?scp=84983430937&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84983430937&partnerID=8YFLogxK
U2 - 10.1016/j.ijpharm.2016.08.033
DO - 10.1016/j.ijpharm.2016.08.033
M3 - Article
C2 - 27543350
AN - SCOPUS:84983430937
SN - 0378-5173
VL - 512
SP - 96
EP - 107
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
IS - 1
ER -